TuHURA Biosciences, Inc.
HURA
$2.16
-$0.43-16.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.45M | 7.16M | 6.10M | 5.13M | 4.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.63M | 27.70M | 24.56M | 21.56M | 19.20M |
| Operating Income | -28.63M | -27.70M | -24.56M | -21.56M | -19.20M |
| Income Before Tax | -30.92M | -30.05M | -29.29M | -27.76M | -23.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.92 | -30.05 | -29.29 | -27.76 | -23.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.92M | -30.05M | -29.29M | -27.76M | -23.50M |
| EBIT | -28.63M | -27.70M | -24.56M | -21.56M | -19.20M |
| EBITDA | -28.55M | -27.63M | -24.49M | -21.48M | -19.10M |
| EPS Basic | -0.61 | -0.64 | -0.66 | -1.06 | -1.28 |
| Normalized Basic EPS | -0.35 | -0.36 | -0.34 | -0.55 | -0.74 |
| EPS Diluted | -0.61 | -0.64 | -0.66 | -1.06 | -1.28 |
| Normalized Diluted EPS | -0.35 | -0.36 | -0.34 | -0.55 | -0.74 |
| Average Basic Shares Outstanding | 208.23M | 191.63M | 176.75M | 138.26M | 105.88M |
| Average Diluted Shares Outstanding | 208.23M | 191.63M | 176.75M | 138.26M | 105.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.03% | -0.03% | -0.02% | -0.02% | -0.01% |